Summary of patient characteristicsa
| IDHmut-Codel (n = 68) | IDHmut-Noncodel (n = 63) | IDHwt (n = 41) | |
|---|---|---|---|
| Sex | |||
| Female | 37 (54.4%) | 30 (47.6%) | 18 (43.9%) |
| Male | 31 (45.6%) | 33 (52.4%) | 23 (56.1%) |
| Age (yr)a | 45.5 (35.5–53) | 33 (27–42.8) | 57.0 (49.5–63.3) |
| WHO grade | |||
| II | 50 (73.5%) | 46 (73.0%) | 25 (61.0%) |
| III | 18 (26.5%) | 17 (27.0%) | 16 (39.0%) |
| Chemotherapy | |||
| Yes | 55 (80.9%) | 53 (84.1%) | 30 (73.2%) |
| No | 13 (19.1%) | 10 (15.9%) | 11 (26.8%) |
| Radiation therapy | |||
| Yes | 45 (66.2%) | 53 (84.1%) | 31 (75.6%) |
| No | 23 (33.8%) | 10 (15.9%) | 10 (24.4%) |
| Presurgical glioma volume (cm3)a | 56.4 (26.5–111.6) | 55.0 (31.0–116.2) | 47.7 (18.0–86.4) |
| Postsurgical glioma volume (cm3)a | 28.4 (13.2–59.1) | 29.3 (1.2–65.6) | 30.1 (8.4–64.4) |
| Mortality events | 12 (17.6%) | 14 (22.2%) | 13 (31.7%) |
↵a Data are listed as median and interquartile range. All other data are listed as absolute values and percentages.